161 Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: the randomized, double-blind, phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 study
Domenica Lorusso, Y. Xiang, Kosei Hasegawa, G. Scambia, Manuel Leiva, Pier Ramos-Elias, A. Acevedo, J. Vizkeleti, A.J.P.D.S. Gomes, Fernando Contreras Mejia, A. Reiss, Ali Ayhan, Jung-Yun Lee, V. Saevets, F. Zagouri, Kan Li, Karin Yamada, Sarper Toker, Sandro Pignata, L. Duska
{"title":"161 Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: the randomized, double-blind, phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 study","authors":"Domenica Lorusso, Y. Xiang, Kosei Hasegawa, G. Scambia, Manuel Leiva, Pier Ramos-Elias, A. Acevedo, J. Vizkeleti, A.J.P.D.S. Gomes, Fernando Contreras Mejia, A. Reiss, Ali Ayhan, Jung-Yun Lee, V. Saevets, F. Zagouri, Kan Li, Karin Yamada, Sarper Toker, Sandro Pignata, L. Duska","doi":"10.1136/ijgc-2024-esgo.3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"19 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
